Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Warford, Jordan R.
Clements, Derek R.
Kennedy, Barry E.
Gujar, Shashi A.
Hoskin, David W.
Easton, Alexander S.
Funding for this research was provided by:
Canadian Institutes of Health Research (130574)
Natural Sciences and Engineering Research Council of Canada (2017-05339)
Dalhousie Medical Research Foundation (34609)